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Objectives. This report from the Asymptomatic Cardiac Isch- 
emia Pilot (ACIP) study examines differences in the magnitude of 
reduction of myocardial ischemia as determined by exercise 
treadmill testing in patients randomized to three different treat- 
ment strategies: angina-guided medical therapy, ischemia-guided 
medical therapy and coronary revascularization. 
Background. No prospective randomized clinical trials in pa- 
tients with exercise lectrocardiographic (ECG) abnormalities 
and asymptomatic ardiac ischemia on ambulatory ECG moni- 
toring have compared the impact of different treatment s rategies, 
including coronary revascularization, i  terms of reducing myo- 
cardial ischemia. 
Methods. The ACIP exercise protocol was used. Exercise vari- 
ables measured included final exercise stage; presence of exercise- 
induced angina or ischemia; time to angina; time to 1-mm ST 
segment depression; umber of exercise ECG leads with abnor- 
malities; maximal depth of ST segment depression in any lead; 
sum of ST segment depression; ST/HR index; and rate-pressure 
product at time to angina, at time to l-ram ST segment depression 
and at peak exertion. 
Results. Peak exercise time was increased by 0.5, 0.7 and 
1.6 rain in patients assigned to the angina-guided, ischemia- 
guided and coronary revascularization strategies, respectively, 
from the qualifying visit to the 12-week visit (p < 0.001). At the 
qualifying visit, the sum of exercise-induced ST segment depres- 
sion was 9.4 -+ 5.0 (mean -+ SD), 9.6 + 4.7 and 9.9 -+ 5.5 mm (p = 
NS) in the three treatment strategies, respectively. At the 12-week 
visit, the sum of exercise-induced ST segment depression was 
7.4 -+ 5.7, 6.8 -+ 5.3 and 5.6 + 5.6 mm (p = 0.02) in the three 
treatment strategies, respectively. Each treatment strategy re- 
sulted in a significant reduction in all exercise-induced variables 
of myocardial ischemia measured at 12 weeks. 
Conclusions. Coronary revascularization significantly reduced 
the extent and frequency of exercise-induced myocardial ischemia 
compared with either medical strategy. The prognostic impact of 
these observations should be evaluated in a large-scale multi- 
center clinical trial. 
(JAm CoU Cardiol 1995;26:585-93) 
The Asymptomatic Cardiac Ischemia Pilot (ACIP) study is a 
National Institutes of Health-sponsored trial designed to as- 
sess the impact of three different treatment strategies in 
reducing manifestations of myocardial ischemia measured by 
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ambulatory electrocardiography andexercise treadmill testing 
(1-3). The three treatment strategies were 1) angina-guided 
medical therapy, 2) angina-guided plus ambulatory electrocar- 
diographic (ECG) ischemia-guided medical therapy, and 
3) coronary revascularization. Each treatment s rategy reduced 
the frequency and duration of myocardial ischemia during 
ambulatory ECG monitoring and prolonged the time to onset 
of exercise-induced ischemic ST segment depression and an- 
gina at the 12-week visit after randomization compared with 
that at the qualifying visit, with the greatest improvement in 
patients who were assigned to coronary revascularization (3). 
The primary end point in the ACIP study was absence of 
cardiac ischemia on the 48-h ambulatory ECG at the 12-week 
visit. Secondary end points included exercise test outcome 
measurements, additional measurements from the ambulatory 
ECG and clinical outcomes. 
Of the 558 randomized patients in the ACIP study, 545 
(98%) had interpretable exercise treadmill test results at the 
qualifying visit and 504 (90%) at the 12-week visit. All rest and 
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Table l. Number of Patients Available for 12-Week Visit Exercise Test Analysis 
,~mgina-Guided lschemia-Guided Revascularization 
Strategy Strategy' Strategy 
Randomized 183 183 192 
ETI" 
Quali~'ing visit 177 178 190 
12-wk visit 164 167 173 
Qualifying visit and 12-wk visit 164 166 172 
E'FI - exercise treadmill test, 
exercise ECGs were sent to a core laboratory facility for 
detailed analysis in blinded manner. The present report con- 
tains a complete analysis of the rest and exercise ECG data for 
the three randomized treatment strategies at the qualifying 
visit and at the 12-week visit after randomization. The aim of 
the present report is to examine the ACIP secondary exercise 
end point measurements further and determine whether the 
magnitude of ischemic response as measured by extent of ST 
segment depression; number of ECG leads with abnormal 
findings; ST/HR index; and hemodynamic response at ST 
segment depression onset, angina onset and peak exertion are 
significantly influenced by assigned treatment s rategy. 
Methods  
Patients. The ACIP study protocol has previously been 
described (1,2). Men and women with obstructive coronary 
disease suitable for revascularization, at least one episode of 
asymptomatic cardiac ischemia on the 48-h ambulatory ECG 
and evidence of exercise-induced myocardial ischemia on 
treadmill testing (n = 548), reversible myocardial perfusion 
defect on intravenous dipyridamole scintigraphic maging (n = 
9) or abnormal results on the exercise ECG arm ergometric 
study (n = 1) were considered eligible for the ACIP study. 
Clinical and angiographic characteristics of the study patients 
at the qualifying visit revealed no significant differences, with 
the exception of peripheral vascular disease, which was more 
frequent in patients in the ischemia-guided strategy, and a 
history of cigarette smoking, which was less frequent in the 
group randomized tothe revascularization strategy. A detailed 
description of clinical and angiographic characteristics of the 
ACIP patient cohort has previously been published (1,2). Data 
reported here are for 558 patients (all 60 patients from one 
clinical unit have been excluded as previously reported [4]). 
At the qualifying visit, the exercise treadmill test was per- 
formed and the ambulatory, ECG recorded after anti-ischcmic 
drug therapy had been discontinued for at least 2 to 3 days, 
except for a small number of patients who were permitted to 
continue taking background medication: 49 (9%) received 
beta-adrenergic blocking agent therapy within 48 h and 41 
(7%) calcium channel blocking agent herapy within 24 h of 
exercise treadmill testing. At the qualifying visit, 177, 178 and 
190 patients in the angina-guided, ischemia-guided and coro- 
nary revascularization strategies, respectively, had interpret- 
able exercise treadmill study results (Table 1). At the 12-week 
visit, there were 164, 167 and 173 patients, respectively. All 
protocol rest and exercise ECGs were analyzed at the core 
ECG laboratory facility. The rest ECGs were classified accord- 
ing to the Minnesota code (5). The protocol was approved by 
the Institutional Review Board of each participating center, 
and procedures followed were in accord with institutional 
guidelines. Written informed consent was obtained from all 
patients before randomization. 
Medical therapy. In the two medical strategies, incremen- 
tal levels of anti-ischemic drug therapy were used to reduce 
symptoms of angina, and additional active medication and 
placebo were prescribed ina blinded manner in patients assigned 
to the ischemia- and angina-guided strategies, respectively, if 
persistent ischemic changes were seen on the ambulatory ECG at 
4 and 8 weeks after andomization according to protocol (2). The 
medical drug regimens included iltiazem followed by isosorbide 
dinitrate if necessary oratenolol followed by nifedipine if neces- 
sary. In 357 patients (64%) eligible to receive ither medication 
regimen, the choice of drug therapy was randomized. Of the 
remaining medically assigned patients, 18% received the atenolol/ 
nifedipine regimen and 18%, the diltiazem/isosorbide dinitrate 
regimen. The average daily dose of atenolol was 134 mg for 
patients assigned to the ischemia-guided strategy with 61 mg for 
patients in the angina-guided strategy. The average daily dose of 
diltiazem (slow release) in the ischemia-guided strategy was 
289 mg with 181 mg in the angina-guided strategy. At the 
12-week visit, 16%, 15% and 63% of patients in the angina- 
guided, ischemia-guided and coronary revascularization strat- 
egy, respectively, did not require any medication to control 
angina. For patients assigned to the revascularization strategy, 
coronary angioplasty or bypass surgery was selected by the 
patient's physician and the patient. 
Coronary revascularization. Of the 173 patients with an 
exercise test at the 12-week visit who were assigned to coronary 
revascularization, 18never underwent the procedure, 71 un- 
derwent coronary bypass grafting and 84 underwent a coronary 
angioplasty procedure before the 12-week visit. For patients 
who underwent percutaneous transluminal coronary angio- 
plasty, 39% had single-vessel and 61% multivessel disease. In 
patients with multivessel disease, 80% had coronary angio- 
plasty in a single vessel. For patients who underwent coronary 
bypass grafting, the average number of grafts placed per 
patient was 3.0 (range 1 to 5). 
Exercise protocol. The ACIP protocol required exercise 
tests to be performed at specific follow-up visits (2). The data 
JACC Vo|. 26, No, 3 CHAITMAN ET AL. 587 
September 1995:585-93 ASYMPTOMATIC CARDIAC 1SCHEMIA PILOT STUDY 
in this report are the results of the qualifying visit and the 
12-week visit (84 to 182 days) after randomization. 
The exercise test was performed according to the ACIP 
protocol (6). The AClP protocol is a linear protocol with two 
1-min warm-up stages followed by 2-min stages at 3 mph 
designed to gradually increase work load by 1.5-metabolic 
equivalent (MET) increments. A modification of the protocol 
designed for elderly or short patients permitted a walking 
speed of 2 mph with a steeper incremental increase in grade, 
resulting in a similar estimated METs per unit time (7). The 
exercise tests were symptom limited using standard criteria for 
stopping, including clinically serious dysrhythmias, severe an- 
gina pectoris, a drop in systolic blood pressure or central 
nervous system complaints. The 12-lead torso ECG was re- 
corded in the standing position before xercise, at each minute 
during exercise, at peak exertion and each minute after 
exertion or until normalization f exercise-induced ST segment 
changes occurred with the patient in the sitting position for 
5 min. Heart rate and blood pressure were recorded uring 
each exercise stage and for each minute of recovery. Time to 
onset of angina, total exercise duration, rate of perceived 
exertion and reasons for stopping exercise were recorded. 
The exercise ECGs were processed at the Saint Louis 
University Core Laboratory using an off-line quantitative com- 
puterized exercise ECG analysis program as previously de- 
scribed (7,8). Maximal depth of ST segment depression during 
or after exercise was measured using a high resolution digitiz- 
ing board in all leads with ->0.5 mm of ST segment deviation 
and compared with baseline levels. Exercise ECG lead abnor- 
malities were defined as 1) J point and ST segment level 80 ms 
after the J point (ST 80) depression >-1.0 mm and horizontal or 
downsloping ST segment <1 mV/s; or 2) ST 80 depression 
---1.5 mm and upsloping ST segment >1 mV/s compared with 
the ECG tracing at rest. 
The following exercise ECG variables were measured: 
1) maximal depth of ST segment depression in any lead; 
2) number of exercise ECG leads with abnormalities; 3)sum of 
ST segment depression measured inall leads with ->0.5-ram ST 
segment deviation (compared with baseline); and 4) ST/HR 
index, defined as the greatest numerical value of the maximal 
depth of ST segment depression during exercise minus rest 
divided by maximal heart rate minus rest heart rate for any 
lead. The lower the numerical value, the less the myocardial 
ischemic response (9). Time to onset and offset of ischemic ST 
segment depression was determined when any lead (excluding 
aVR) met criteria for abnormality. Heart rate and systolic 
blood pressure were recorded at baseline, at each stage and at 
peak exertion. The rate-pressure product (heart rate × systolic 
blood pressure) was determined at the time to onset of 
ischemic ST segment depression and the time to onset of 
angina. Peak exercise time was recorded, and the reasons for 
stopping exercise were noted. 
The ACIP protocol secondary outcome measures from 
exercise treadmill testing included 1) occurrence of ischemic 
exercise-induced ST segment depression; 2) occurrence of 
exercise-induced angina; 3) heart rate at onset of ischemic ST 
segment depression; 4) time to onset of ischemic ST segment 
depression; 5) total duration of exercise; 6) rate-pressure 
product at time of onset of ischemic ST segment depression 
and at peak exercise; 7) reasons for terminating exercise. At 
the 12-week visit, the percent of patients without an ischemic 
outcome on exercise treadmill testing was defined as absence 
of ischemic ST segment depression, death, myocardial infarc- 
tion or nonprotocol revascularization procedure. 
Statistical considerations. The percent of patients with 
ischemic ST segment depression during the initial 10 min of 
the exercise test (-9 METs) was estimated using the Kaplan- 
Meier method (10,11); patients who did not complete 10 min 
of exercise for reasons other than ST segment depression were 
censored without he event at the time the test was stopped. 
This analytic method was also used to estimate mean time to 
angina onset and mean time to onset of -> 1 mm of ST segment 
depression if >50% of patients had the event. In all analyses, 
patients were included in the groups to which they were 
randomly assigned. Differences among treatment strategies 
were analyzed using analysis of variance. To take account of 
the many hypotheses tested in the ACIP study, p = 0.01 was 
regarded as showing some evidence against the null hypothesis, 
and p = 0.001 was regarded as strong evidence. The closure 
date for analysis was January 18, 1995. 
Results 
At the qualifying visit, 48.4% to 57.4% of patients in the 
three treatment strategies had normal findings on the rest 
ECG. Minnesota code Q wave abnormalities were present in 
10.4% to 13.7% of patients (Table 2). At the 12-week visit, there 
was a difference between treatment groups in the number of 
patients with normal rest ECG results (p < 0.001); a smaller 
number of patients in the revascularization group had normal 
rest ECG findings. The greater frequency of abnormal rest 
ECG results at the 12-week visit in the revascularization group 
was related to the increased prevalence of T wave abnormal- 
ities (48.4%) compared to 23.8% and 31.8% in the two medical 
strategies, respectively (p < 0.001). 
Exercise treadmill results' in the 545 (98%) of 558 patients 
who had an interpretable exercise treadmill test at the quali- 
fying visit are illustrated in Table 3. There were no important 
differences among the three treatment s rategies in any of the 
variables measured. At the 12-week visit, the percent of 
patients without an ischemic episode or event (death, myocar- 
dial infarction, nonprotocol coronary revascularization proce- 
dure, exercise-induced myocardial ischemia) was 18.2%, 19.4% 
and 33.7% in the angina-guided, ischemia-guided and revas- 
cularization strategies, respectively (p < 0.001). Table 4 pro- 
vides the exercise variables at the 12-week visit in the 504 
(90%) of 558 patients who had interpretable r sults. The most 
important differences occurred in patients who underwent 
revascularization compared with those who were assigned to 
the two medical treatment s rategies. In the revascularization 
group, fewer patients had exercise-induced ST segment de- 
pression (p = 0.004) and angina (p = 0.01), and they had less 
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Table 2, Rest Electrocardiographic Findings at Oual i~ing Visit and 12-Week Visit 
Angina-Guided Ischemia-Guided Revascularization 
Strateg) Strategy Strategy 
{n = 183) (n = 1831 (n = 192) 
No. ~ No. c:~ No. % p Value* 
Qualifying visit 
Normal findings llJ5 57.4 89 48.6 93 48.4 
Q wave abnormalities 19 10.4 25 13.7 24 12.5 
ST segment depression 411 21.9 48 26.2 44 22.9 
Major 6 3.3 11 6.0 4 2.1 
Minor 34 18.6 37 20.2 40 20.8 
T wave abnormalities 511 ,:7..~ 55 30.1 65 33.9 
Major 21) 10.9 211 Ilk9 31 16.2 
Minor ~{ 16.4 35 19.1 34 17.7 
12-wk visit 
Rest ECG data available 172 17b 188 
Rest ECG findings 
Normal findings 111 54.5 c12 52.3 76 40.4 
Q wave abnormalities 14 8.1 27 15.3 28 14.9 
ST segment depression 24 t4.11 37 21.11 39 20.7 
Major 2 1.2 4 2.3 9 4.8 
Minor 22 12.8 33 18.8 30 16.0 
T wave abnormalities 41 23.8 56 31.8 91 48.4 
Major 18 10.5 19 10.8 42 22.3 
Minor ~ 37 _.~ 13.4 2 I.O 49 26.1 
< 0.001 
(I.08 
< 0.0fil 
0.001 
0.01 
*Global test of differences among the three treatment strategies: onb' p < 0.10 is reported. Data presented are 
number and percent of patients. ECG = electrocardiographic. 
extensive ischemic ECG patterns than those in the two medical 
treatment groups. Patients assigned to the revascularization 
strategy were able to exercise longer and achieved a higher 
peak heart rate, systolic blood pressure response and rate- 
pressure product. When the 12-week visit exercise treadmill 
results were compared with those at the qualifying visit, peak 
exercise time was increased by 0.5, 0.7 and 1.6 rain in the three 
treatment strategies, respectively (p < 0.001). Rate-pressurc 
product at time to angina and time to onset of ischemic ST 
segment depression were greater in patients assigned to the 
revascularization strategy. The magnitude of difference in 
these variables between patients assigned to the angina-guided 
and ischemia-guided medical strategies was small and not 
statistically significant. The sum of exercise-induced ST seg- 
ment depression was 7.4 +_ 5,7 versus 6.8 + 5.3 ram, and the 
average number of ECG leads with abnormalities was 3.5 -2-_ 2.5 
versus 3.2 _+ 2.3 in the angina-guided versus ischemia-guided 
therapy group, respectively (Fig. 1 to 3). 
Reasons for stopping exercise. When the primary, reasons 
for stopping exercise at the time of the qualifying visit and at 
the 12-week visit were compared, significantly fewer patients 
stopped exercising because of angina at the 12-week visit in the 
ischemia-guided strategy (p -- 0.00l) and in the coronary 
revascularization strategy (p < 0.001) (Table 5), Fatigue or 
exhaustion was a significantly more frequent primary reason 
for stopping exercise at the 12-week visit in the ischemia- 
guided strategy (p = 0.001) and in the revascularization 
strategy (p < 0.001). There werc significantly fewer patients 
with exercise-induced ST segment depression >3 mm at the 
12-week visit than at the qualifying visit in the coronary 
revascularization strategy (p < 0.001). There were no signifi- 
cant differences in the primary reason for stopping exercise 
when the qualifying and the 12-week visit results were com- 
pared in patients randomized to the angina-guided strategy. A
similar percent of patients topped exercising for dyspnea in 
each of the three treatment strategies at the qualifying and 
12-week visits. 
Exercise test response with medical therapy. Exercise test 
variables at the qualifying visit were similar in patients ran- 
domly assigned to the initial beta-blocker strategy compared 
with those assigned to the initial calcium channel blocker 
strategy. At the 12-week visit, mean exercise time was 7.3 _+ 
3.3 versus 7.5 _+ 3.7 min in the atenolol/nifedipine v rsus 
diltiazem/isosorbide dinitrate group, respectively, (p = NS). A 
similar percent of patients in each medication regimen had 
exercise-induced ischemia ST segment changes by 10 rain. 
Time to onset of ischemic ST segment depression and percent 
of patients with angina were similar in both groups. 
Cardiac events from time of qualifying visit to 12-week visit 
in patients who underwent exercise treadmill testing. Of the 
patients who performed an exercise test at the 12-week visit, 
one, two and three patients, respectively, had sustained a 
myocardial infarction in the angina-guided, ischemia-guided 
and coronary revascularization strategy groups by day 84. One 
additional patient had a myocardial infarction after day 84 but 
before the 12-week exercise test in the angina-guided strategy 
group. A nonprotocol revascularization procedure was per- 
formed bv 84 days in 7, 6 and 5 patients, respectively. One 
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Table 3. Qualifying Visit Exercise Treadmill Test Results 
Angina-Guided Ischemia-Guided Revascularization 
Strategy Strategy Strategy 
(n = 177) (n = 178) (n = 190) 
P 
Value* 
>_l-ram ST segment depression? 165 (95.8) 170 (97.6) 176 (96.8) 
Exercise-induced angina? 86 (61.4) 93 (60.3) 95 (62.5) 
Final stage (METs) 7.5 _+ 2.3 7.3 +_ 2.3 7.3 + 2.3 
Total exercise time (rain) 7.0 ± 3.4 6.8 -+ 3.2 6.7 _+ 3.1 
Measurements at final stage 
HR (beats/min) 133,3 -+ 17,4 129.4 _+ 20.4 132.5 -+ 18.7 
SBP (mm Hg) 175,2 _+ 25,2 177.8 _+ 22.7 172.3 -+ 26.8 
RPP (x l0  3) 23,5 + 5.2 23.1 + 5,4 23.0 -+ 5.3 
% of age-predicted maximal HR 84,0 -+ 10,9 81.7 -+ 12.6 83.6 _+ 11.9 
No. of exercise ECG leads 4,4 +- 1.8 4.5 +- L7 4.4 +_ 1.9 
with abnormalities 
Maximal depth of ST segment 2.4 _+ 0.9 2.4 + 0,9 2.5 _+ 1.1 
depression in any lead 
Sum of ST segment depression 9.4 -- 5.0 9.6 -+ 4.7 9.9 -+ 5.5 
ST/HR index 4.9 _+ 3.2 5.1 _+ 3.0 4.8 _+ 2.6 
Time to 1-mm ST segment 4.6 2 0.2 4.4 +_ 0.2 4.3 -+ 0.2 
depression (min):~ 
Measurements for pts with 
->l-mm ST segment depression 
No. of pts 165 170 176 
HR (beats/min) 123.1 _+ 15.7 120.4 - 16.8 121.6 ± 17.6 
SBP (mm Hg) 168.2 _+ 23.9 172.8 _+ 22.1 165.8 ± 24.3 
RPP (x l0  -3) 20.8 + 4.6 20.9 _+ 4.5 20.3 + 4.8 
Time to angina (min):~ 6.9 +_ 0.2 6.1 +_ 0.2 6.8 + 0.2 
Measurements for pts with 
exercise-induced angina 
No. of pts 86 93 95 
HR (beats/min) 124,0 -+ 15.6 119.9 _+ 17.3 123.1 ± 18.8 
SBP (mm Hg) 166.8 -+ 24.0 169.3 ± 22.4 165.6 ± 23.5 
RPP (x l0  3) 20,8 _+ 4.5 20.5 _+ 4.9 20.5 ± 4.7 
0.02 
* Only p < 0.10 is reported. ~Kaplan-Meier life-table analysis used to calculate percent of patients (pts) with specified 
event during first 10 min of exercise; occurrences after 10 min or during recovery are not counted. :~Kaplan-Meier 
life-table analysis used to estimate mean (+_SE) time to event during first 10 min of exercise; occurrences after 10 rain 
or during recovery are not counted. Data presented are number (%) of patients, mean value -+ SD or mean value + SE. 
HR = heart rate; METS = metabolic equivalents; RPP = rate-pressure product (units); SBP = systolic blood pressure; 
ST/HR index = (Maximal ST depression - Rest STso)/(Maximal heart rate - Rest heart rate). 
patient in the ischemia-guided strategy group had a procedure 
after day 84 but before the 12-week exercise test. 
Discuss ion  
The exercise test results of the ACIP study reveal a 
significant reduction in ischemic responses for each of the 
three treatment s rategies. Peak exercise time was increased by 
0.5, 0.7 and 1.6 min in the three treatment strategies, and the 
extent of reduction in maximal depth of ST segment depres- 
sion in any lead from the qualifying visit to the 12-week visit 
ranged from 0.6 to 1.2 mm. However, at the 12-week visit, 69% 
to 88% of patients had persistent abnormal exercise-induced 
ST segment depression. 
The magnitude of reduction in exercise-induced myocardial 
ischemic responses in the ACIP study patients treated with 
medical therapy is similar to that in previous reports using 
comparable drug regimens (12-16). The range of prolongation 
of exercise time in three studies comparing atenolol with 
baseline or placebo measurements was 1.1 to 1.9 min, with 
maximal reduction in depth of ST segment depression ranging 
from 0.03 to 1.05 mm (14-16). The time to onset of ischemic 
ST segment depression was prolonged by 2 min (14). In the 
ACIP study, the prevalence of abnormal findings on the 
exercise ECG interpreted at the core ECG laboratory facility 
was 96% at the qualifying visit and 86% at the 12-week visit 
after randomization i  the two medical strategies. The net 10% 
reduction in frequency of abnormal exercise ECG responses at 
the 12-week postrandomization visit is similar to the 6% to 
11% normalization of ischemic exercise ECG responses in the 
series reported by Theroux et al. (12), Steffensen et al. (14) and 
de Muinck et al. (15). The ACIP data confirm that exercise- 
induced myocardial ischemia is rarely suppressed completely 
after medical therapy. 
Coronary revascularization. The greatest magnitude of 
improvement in exercise-induced myocardial ischemia was 
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Table 4. Outcomes of 12-Week Exercise Treadmill Test 
Angina-Guided lschemia-Guided Revascularization 
Strategy Strategy, Strategy p 
(n = 164) (n - 167) (n = 173) Value* 
> I-mm ST segment depression+ 122 (85.0) 122 (88. I) 101 (69.2) 0.004 
Exercise-induced angina'i 54 (47.6) 50 (40.5) 36 (24.7) 0.01 
Final stage (METs) 7.9 + 2.4 7.9 +_ 2.4 8.5 -+ 2.4 0.05 
Total exercise time (min) 7.6 + 3.3 7.6 + 3.4 8.3 + 3.5 0.06 
Measurements at linal stage 
HR (bcats/min) 123.9 + 19.8 115.9 + 19.9 138.3 ___ 22.7 < 0.001 
SBP (ram Hg) 166.4 + 25.7 lf,7.8 + 26.2 177.0 + 26.4 < 0.001 
RPP (×ltl ~) 20.8 _* 5.2 19.7 _+ 5.4 24.6 + 6.l < 0.001 
% of age-predicted maximal HR 78.0 - 12.11 73.2 - 12.5 87.2 -+ 14.1 < 0.001 
No. of exercise ECG leads 3.5 _+ 2.5 3.2 + 2.3 2.6 + 2.5 0.002 
with abnormalities 
Maximal depth of ST segment 1.8 ~ 12 1.7 +_ 1.2 1.3 ___ 1.3 0.008 
depression i  any lead 
Sum of ST segment depression 7.4 + 5.7 6.8 _+ 5.3 5.6 ± 5.6 0.02 
ST/HR index 3.7 + 2.8 3.8 + 3.6 2.3 _+ 2.2 < 0.001 
Time to l-ram ST segment 6.0 ~ 0.2 6.2 _+ 0.2 6.8 ± 0.2 0.004 
depression (min)$ 
Measurements for pts with 
-> l-ram ST segment depression 
No. of pts 122 122 10l 
HR (beats/min) 115.3 + 153) 110.1 + 15.6 125.1 ~+ 19.0 < 0.001 
SBP [ram Hg) 163.6 + 22.7 162.5 + 24.4 169.5 + 24.(/ 0.07 
RPP ( × 10 ~} 19.0 + 4.4 18.0 _+ 4.6 21.4 + 5.2 < 0.001 
Time to angina (minis NA NA NA 
Measurements for pts 
with exercise-induced angina 
No. of pts 54 50 36 
HR (beats/rain) 116.3 ± 17.5 106.4 +_ 16.6 120.7 -~ 21.0 < 0.001 
SBP (ram Hg) 160.7 _+ 23.5 158.4 + 26.5 167.3 _+ 26.2 
RPP (×10 ~) 18.8 + 4.5 17.0 + 4.9 20.4 _+ 5.7 0.01 
* Only p < 0. I0 is reported, tKaplan-Meier life-table analysis used to calculate percent of patients (pts) with specified 
event during first 10 rain of exercise; occurrences after 10 min or during recovery are not counted. :~Kaplan-Meicr 
life-table analysis used to estimate mean (_+SE) time to event during first 10 rain of exercise; occurrences after 10 rain 
or during recove U are not counted. Data presented are number (%) of patients, mean value _+ SD or mean value + SE. 
NA only available if >50c4 of patients had an event; other abbreviations a in Table 3. 
seen in the ACIP study patients who underwent coronary 
revascularization, an observation also reported in previous 
randomized clinical trials comparing medical therapy with 
coronary revascularization (17-24). The mean maximal depth 
of ST segment depression seen in any lead was reduced by 
1.2 ram. 
In a 57-patient series reported by Vandormael et al. (17), 
patients who underwent exercise treadmill testing before and 
within 10 days of multilesion coronary angioplasty, exercise 
time was prolonged by 2.3 and 1.9 rain in those with complete 
versus incomplete revascularization. Exercise-induced angina 
was abolished in 27 patients who had complete revasculariza- 
tion, although 26% of patients continued to have isehemic ST 
segment depression on the exercise ECG. Of the 30 patients 
with incomplete revascularization, 20% continued to have 
exercise-induced angina and 37c4 ischemic ST segment depres- 
sion. 
Gohlke et al. (21) reported abnormal exercise ECG re- 
sponses in 20%, 29% and 47~ of patients who had complete, 
Figure I. Cumulative distribution for percent of patients in the angina- 
guided strategy according to the sum of exercise-induced ST segment 
depression at the qualifying visit (QV)  and at the 12-week visit 
(WK12). After medical treatment,  the extent of exercise-induced 
ST segment depression was less than that at the qualifying visit. 
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Figure 2. Cumulative distribution for percent of patients in the 
ischemia-guided strategy according tothe sum of exercise-induced ST 
segment depression atqualifying visit (OV) and at the 12-week visit 
(WK12). The percent of patients with a greater extent of ST segment 
depression was lower at the 12-week visit han at the qualifying visit. 
sufficient and incomplete r vascularization, respectively, 1 year 
after coronary bypass grafting. In the Coronary Artery Surgery 
Study (24), 6 months after randomization, the incidence of 
exercise-induced ischemic ST segment depression and angina 
was 55% and 42% in the group assigned to medical therapy 
compared with 25% and 9% in the group assigned to coronary 
bypass urgery. In ACIP study, Bourassa et al. (25) reported a
significant reduction in frequency and extent of myocardial 
ischemia on ambulatory electrocardiography and exercise test- 
ing after coronary bypass grafting compared with that after 
coronary angioplasty. 
In the ACIP study, each treatment strategy reduced the 
frequency and duration of myocardial ischemia during ambu- 
latory ECG monitoring and prolonged the time to onset of 
Figure 3. Cumulative distribution for percent of patients in the 
revascularization strategy according tothe sum of exercise-induced ST 
segment depression at the qualifying visit (QV) and at the 12-week visit 
(WK12). The sum of exercise-induced ST segment depression was 
significantly less at the 12-week visit than at the qualifying visit, with 
the magnitude of reduction significantly greater than that observed for 
the two medical strategies (Fig. 1 and 2). 
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exercise-induced angina nd ischemic ST segment depression 
at the 12-week visit compared with that at the qualifying visit; 
yet, there was a relatively high proportion of patients (69.2%) 
with persistent exercise-induced myocardial ischemia after 
revascularization treadmill testing at the 12-week visit. This 
finding can be explained in part by the following: 1) 10% of 
patients never received coronary revascularization but were 
analyzed in the revascularization group by treatment assign- 
ment; 2) the relatively high proportion of patients with mul- 
tivessel disease who underwent single-vessel coronary angio- 
plasty; 3) the probability that restenosis contributed to the 
exercise-induced myocardial ischemia response in perhaps as 
many as 30% of patients in the angioplasty group, based on 
data from other studies (17,22,23). 
Rest ECG findings. In the medically treated strategies, a
greater proportion of patients had normal rest ECG results at 
the 12-week visit than at the qualifying visit. The difference was 
mainly due to a reduction i  frequency of ST segment depres- 
sion. In contrast, at the 12-week visit after coronary revascu- 
larization, T wave abnormalities were more frequent than at 
the time of the qualifying visit, as expected. In patients with 
documented coronary disease, rest ECG abnormalities are 
associated with a significant increased long-term risk of subse- 
quent cardiac events (26,27). The prognostic impact of the 
small reduction i  rest ST segment depression i  the medically 
treated group in the ACIP study is unknown. 
Comparison with earlier studies: limitations. In the ACIP 
study, persistent myocardial ischemic responses were common 
at the 12-week visit in patients randomly assigned to the 
medical treatment s rategies as well as in patients assigned to 
coronary revascularization. The range of persistent ischemic 
responses on the ambulatory ECG and during exercise tread- 
mill testing at the 12-week visit, was 46% to 61% (28) and 69% 
to 88%, respectively. Increased myocardial oxygen demand 
associated with exercise treadmill testing compared with that 
on ambulatory electrocardiography may explain in part the 
greater frequency of ischemic responses on treadmill testing. 
The ACIP protocol entry criteria required an ambulatory 
ECG abnormalities and, whenever an exercise treadmill test 
was feasible (98% of patients), evidence for exercise-induced 
myocardial ischemia. Patients were included if they had evi- 
dence for coronary disease on angiography and were excluded 
if ECG abnormalities precluded analysis of the ambulatory 
ECG. In addition, all randomized ACIP study patients had to 
be eligible for coronary revascularization a d treatment with a 
beta-blocker or calcium channel blocker drug. The analyses in 
the present report are based on treatment assignments by 
randomization. At the 12-week visit, 16% of patients in the 
angina-guided strategy were taking no antianginal medica- 
tion, and 10% of patients randomly assigned to coronary 
revascularization did not undergo a revascularization pro- 
cedure. The choice of revascularization procedure (coro- 
nary angioplasty or bypass grafting) was not randomly 
assigned; rather, it was recommended according to standard 
and customary guidelines at the participating institutions. In
the medically treated ACIP study patients, 20% were taking 
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Table 5. Primary Reason for Stopping Exercise 
Qualifying Visit 12-wk Visit 
Angina-Guided Ischemia-Guided Revascularization Angina-Guided lschemia-Guided Revascularization 
Strategy Strategy Strategy Strategy Strategy Strategy 
No. % No. % No. % No. % No. % No. % 
ETT performed 177 178 1911 164 167 173 
Angina 45 25.4 47 26.4 48 25.3 29 17.7 20 12.0 17 9.8 
Fatigue/exhaustion 60 33.9 52 29.2 62 32.6 70 42.7 80 47.9 96 55.5 
Dyspnea 20 11.3 21 ll.8 20 10.5 21 12.8 24 14.4 18 10.4 
Physician request 18 1//.2 16 9.0 16 8.4 16 9.8 14 8.4 15 8.7 
ST segment depression 15 8.5 17 9.6 27 14.2 10 6.1 6 3.6 7 4.1 
->3.0 mm 
Hypotension 1 0.6 2 1.1 1 11.5 2 1.2 4 2.4 0 0 
Other 18 1[1.2 23 12.9 16 8.4 16 9.8 19 11.4 20 11.6 
Data presented are number or percent of patients. ETI = exercise treadmill test. 
antianginal medication at the time of baseline exercise 
testing. 
Conclusions. There are few randomized trials in patients 
with silent myocardial ischemia that examine the impact of 
treatment s rategies, including coronary revascularization, on
long-term outcome. In the ASIST trial, Pepine et al. (29) 
reported a reduction in number and duration of ambulatory 
ischemic episodes after 4 weeks of treatment with atenolol 
compared with placebo in a randomized trial of asymptomatic 
or minimally symptomatic outpatients with coronary artery 
disease. After 1 year of therapy, cardiac event rates were 
significantly reduced in the group that received atenolol treat- 
ment. In the ACIP study, Rogers et al. (28) reported a 1-year 
mortality rate of 4.4% (eight deaths) in the angina-guided 
group, 1.6% (three deaths) in the ischemia-guided group, and 
0% in the revascularization group (p = 0.01). Although the 
numbers of deaths in both studies were small, the pilot data 
suggest a reduction in cardiac event rates for patients with 
silent myocardial ischemia fter medical therapy and particu- 
larly after coronary revascularization. The pilot data from both 
trials indicate a reduction in cardiac event rates for patients 
with silent myocardial ischemia after medical therapy and 
particularly after coronary revascularization. A large-scale 
multicenter clinical trial will be necessary to evaluate the 
impact of the magnitude of reduction of myocardial ischemia 
on ambulatory electrocardiography and exercise testing in 
patients with silent myocardial ischemia nd the subsequent 
impact on prognosis. 
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